肝细胞腺瘤的分子分型与危险因素、出血及恶性转化的关联
该研究分析了来自28个中心411例患者的533个肝细胞腺瘤样本,基于20个基因表达和8个基因外显子区域测序,将肝细胞腺瘤分为8个分子亚型。新发现一个由INHBE与GLI1基因融合激活音猬因子信号通路的亚型,占全部肝细胞腺瘤的4%,与肥胖和出血相关。特定分子亚型分别与β-catenin激活相关的恶性转化和音猬因子激活相关的出血相关,该分类系统可能用于选择治疗策略。
要点
- 肝细胞腺瘤可分为8个分子亚型,新发现INHBE-GLI1融合激活音猬因子信号的亚型占4%。
- 症状性出血发生于14%的患者,7%的结节为肝细胞腺瘤与肝细胞癌交界性,3%的患者由肝细胞腺瘤发展为肝细胞癌。
- β-catenin和音猬因子激活的分子亚型分别与恶性转化和出血相关。
核心结论
- 基于测序和基因表达分析,识别出以INHBE与GLI1基因融合及音猬因子通路激活为特征的肝细胞腺瘤亚型。
- 肝细胞腺瘤的分子亚型与患者不同的肝细胞腺瘤危险因素、疾病进展和肿瘤病理特征相关。
- 该分类系统可能用于选择肝细胞腺瘤患者的治疗策略。
研究设计与样本
- 分析了来自28个中心(主要位于法国)2000年至2014年收集的411例患者的533个肝细胞腺瘤的607个样本。
- 检测20个基因的表达水平,并对8个基因(HNF1A、IL6ST、CTNNB1、FRK、STAT3、GNAS、JAK1和TERT)的外显子区域进行测序。
- 对选定样本进行基因表达谱、RNA测序、全外显子和基因组测序及免疫组化分析。
- 将分子数据与危险因素、组织病理学、出血和恶性转化进行关联分析。
主要发现
- 症状性出血发生于14%的患者(其中85%为女性,中位年龄38岁)。
- 7%的结节为肝细胞腺瘤与肝细胞癌交界性,3%的患者由肝细胞腺瘤发展为肝细胞癌。
- 基于分子特征将肝细胞腺瘤分为8个亚组。
- 一个新亚组由先前未分类的肝细胞腺瘤组成,占全部肝细胞腺瘤的4%,与肥胖和出血相关,其特征为INHBE启动子与GLI1融合的局灶性缺失导致音猬因子信号激活。
- 对来自不同患者的多发肝细胞腺瘤进行遗传异质性分析,揭示了分子亚型场效应;多个肿瘤具有不同突变但 deregulated 相似通路。
临床怎么用
- 作者认为该分类系统可能用于选择肝细胞腺瘤患者的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Hepatocellular adenomas (HCAs) are benign liver tumors that can be assigned to molecular subtypes based on inactivating mutations in hepatocyte nuclear factor 1A, activating mutations in β-catenin, or activation of inflammatory signaling pathways. We aimed to update the classification system for HCA and associate the subtypes with disease risk factors and complications. METHODS: We analyzed expression levels of 20 genes and sequenced exon regions of 8 genes (HNF1A, IL6ST, CTNNB1, FRK, STAT3, GNAS, JAK1, and TERT) in 607 samples of 533 HCAs from 411 patients, collected from 28 centers mainly in France from 2000 and 2014. We performed gene expression profile, RNA sequence, whole-exome and genome sequence, and immunohistochemical analyses of select samples. Molecular data were associated with risk factors, histopathology, bleeding, and malignant transformation. RESULTS: Symptomatic bleeding occurred in 14% of the patients (85% of cases were female, median age, 38 years); 7% of the nodules were borderline between HCA and hepatocellular carcinoma, and 3% of patients developed hepatocellular carcinoma from HCA. Based on molecular features, we classified HCA into 8 subgroups. One new subgroup, composed of previously unclassified HCA, represented 4% of HCAs overall and was associated with obesity and bleeding. These tumors were characterized by activation of sonic hedgehog signaling, due to focal deletions that fuse the promoter of INHBE with GLI1. Analysis of genetic heterogeneity among multiple HCAs, from different patients, revealed a molecular subtype field effect; multiple tumors had different mutations that deregulated similar pathways. Specific molecular subtypes of HCA associated with various HCA risk factors, including imbalances in estrogen or androgen hormones. Specific molecular subgroup of HCA with β-catenin and sonic hedgehog activation associated with malignant transformation and bleeding, respectively. CONCLUSIONS: Using sequencing and gene expression analyses, we identified a subgroup of HCA characterized by fusion of the INHBE and GLI1 genes and activation of sonic hedgehog pathway. Molecular subtypes of HCAs associated with different patients' risk factors for HCA, disease progression, and pathology features of tumors. This classification system might be used to select treatment strategies for patients with HCA.
引用
- Nault JC, Couchy G, Balabaud C, et al. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation. Gastroenterology. 2016. PMID: 27939373. doi:10.1053/j.gastro.2016.11.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。